Search
for
Sort by
Research 241–270 of 1000+
- Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment
- Frontiers in alopecia areata pathobiology research
- Successful treatment of alopecia universalis with abrocitinib: a case report
- Astilbin Activates the Reactive Oxidative Species/PPARγ Pathway to Suppress Effector CD4+ T Cell Activities via Direct Binding With Cytochrome P450 1B1
- Nanostructured lipid carriers promote percutaneous absorption and hair follicle targeting of tofacitinib for treating alopecia areata
- Minoxidil Sulfate Regulates JAK / STAT Signalling and Mitochondrial Function in Alopecia Areata
- Understanding the Role of Type I Interferons in Cutaneous Lupus and Dermatomyositis: Toward Better Therapeutics
- Immunomodulators in the treatment of cutaneous lymphoma
- Decreased CD19+CD24hiCD38hi Regulatory B Cells in Alopecia Areata
- Alopecia Areata: A possible extraintestinal manifestation of Crohn's disease
- Evaluation of methotrexate-loaded surfactants, ceramides and cholesterol-based lamellar phases as a topical treatment for psoriasis
- The AhR pathway is dysregulated in alopecia areata
- A meta-analysis of chemokines in alopecia areata: recruiting immune cells toward the hair follicle
- Ox40-Cre–mediated deletion of BRD4 reveals an unexpected phenotype of hair follicle stem cells in alopecia
- Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
- Lichen planopilaris is characterized by immune privilege collapse of the hair follicle's epithelial stem cell niche
- Cutaneous Reactions to Chemotherapeutic Agents
- Lichen planus and other cutaneous manifestations in chronic hepatitis C: pre- and post-interferon-based treatment prevalence vary in a cohort of patients from low hepatitis C virus endemic area
- Evaluation of the Relationship between Alopecia Areata and Viral Antigen Exposure
- Exacerbation of alopecia areata during pegylated interferon alpha-2b and ribavirin therapy, possibly due to the collapse of hair follicle immune privilege
- Rare and common manifestations of COVID‐19 in children
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- SnapshotDx Quiz: April 2022
- Hair follicles as immune targets: unraveling cellular players, cytokine crosstalk, and precision pathways for future therapy of alopecia areata
- Janus Kinase Inhibitors against Other Biological Treatments in Alopecia Areata
- JAK Family Expression and Therapeutic Implications in Primary Cicatricial Alopecias
- Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report
- Inflammatory priming enhances mesenchymal stromal cell secretome potential as a clinical product for regenerative medicine approaches through secreted factors and EV-miRNAs: the example of joint disease
- Predictive factors for adverse dermatological events during pegylated/interferon alpha and ribavirin treatment for hepatitis C
- Sudden improvement of alopecia universalis and psoriatic arthritis while receiving upadacitinib: a case-based review